Skip to main content
. 2020 Apr 23;3(4):e203482. doi: 10.1001/jamanetworkopen.2020.3482

Figure 2. Change in MMP-9 and TIMP-1 Levels.

Figure 2.

Each panel shows the estimate of means with 99.8% CIs, whereby treatment effect is defined as the change (ie, posttreatment minus pretreatment) at each day for a given treatment. Therefore, a nonzero mean difference indicates a treatment effect for the given day and treatment (placebo vs standard-dose azithromycin [AZM] vs high-dose AZM) for the cytokines measured in the nasal and endotracheal secretions. MMP-9 indicates matrix metalloproteinase–9; and TIMP-1, tissue inhibitor of metalloproteinase–1.